Last Close
Apr 02  •  04:00PM ET
0.6300
Dollar change
-0.0100
Percentage change
-1.56
%
Index- P/E- EPS (ttm)-0.75 Insider Own53.39% Shs Outstand15.52M Perf Week-0.02%
Market Cap3.16M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.34M Perf Month8.43%
Enterprise Value6.41M PEG- EPS next Q- Inst Own0.58% Short Float0.39% Perf Quarter-47.93%
Income-3.19M P/S0.76 EPS this Y- Inst Trans-6.48% Short Ratio0.18 Perf Half Y-67.46%
Sales4.14M P/B0.43 EPS next Y- ROA-13.78% Short Interest0.01M Perf YTD-47.93%
Book/sh1.48 P/C9.03 EPS next 5Y- ROE-20.67% 52W High2.64 -76.18% Perf Year-74.82%
Cash/sh0.07 P/FCF35.11 EPS past 3/5Y73.01% 53.14% ROIC-13.84% 52W Low0.50 25.92% Perf 3Y-96.77%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-20.03% -17.53% Gross Margin-23.73% Volatility9.32% 10.16% Perf 5Y-99.87%
Dividend TTM- EV/Sales1.55 EPS Y/Y TTM72.59% Oper. Margin-78.16% ATR (14)0.07 Perf 10Y-99.30%
Dividend Ex-Date- Quick Ratio0.10 Sales Y/Y TTM-8.49% Profit Margin-76.91% RSI (14)48.08 Recom-
Dividend Gr. 3/5Y- - Current Ratio0.32 EPS Q/Q61.71% SMA203.97% Beta1.10 Target Price-
Payout- Debt/Eq0.16 Sales Q/Q8.11% SMA50-13.18% Rel Volume0.55 Prev Close0.64
Employees221 LT Debt/Eq0.00 Earnings- SMA200-55.46% Avg Volume50.34K Price0.63
IPOApr 17, 2002 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume27,455 Change-1.56%
Date Action Analyst Rating Change Price Target Change
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $6
Apr-04-25 04:05PM
Dec-18-24 08:30AM
Dec-13-24 08:00AM
Aug-19-24 08:00AM
Feb-23-24 04:05PM
08:00AM Loading…
Nov-29-23 08:00AM
Aug-23-23 07:34PM
Aug-09-23 08:30AM
Feb-24-23 04:05PM
Dec-28-22 08:00AM
Dec-15-22 08:00AM
Dec-05-22 08:00AM
Dec-02-22 04:10PM
Oct-01-22 10:05PM
Jul-18-22 08:00AM
05:00PM Loading…
Jun-22-22 05:00PM
Mar-31-22 08:00AM
Nov-12-21 04:30PM
Aug-13-21 04:30PM
Aug-05-21 09:00AM
Jun-09-21 08:00AM
May-14-21 04:30PM
Apr-19-21 08:30AM
Mar-26-21 05:00PM
Nov-13-20 04:10PM
Oct-11-20 09:23AM
Sep-21-20 08:30AM
Aug-14-20 06:30AM
Aug-11-20 10:10AM
Jun-04-20 07:59PM
06:30AM Loading…
May-15-20 06:30AM
Apr-15-20 08:00AM
Apr-14-20 04:30PM
07:10AM
Apr-05-20 01:17AM
Mar-31-20 06:30AM
Mar-13-20 08:30AM
Mar-02-20 07:00AM
Dec-31-19 08:01AM
Nov-15-19 08:00AM
Oct-28-19 07:39AM
Sep-13-19 07:17AM
Sep-11-19 08:00AM
Sep-06-19 08:31AM
Aug-15-19 06:30AM
May-21-19 07:56PM
May-15-19 06:00AM
May-07-19 08:00AM
Mar-29-19 06:00AM
Jan-08-19 12:58PM
Nov-23-18 08:55AM
Nov-15-18 06:00AM
Nov-13-18 08:00AM
Nov-12-18 08:00AM
Oct-10-18 06:44PM
Aug-15-18 06:00AM
Aug-06-18 08:45AM
May-15-18 08:00AM
06:00AM
May-08-18 08:00AM
Apr-06-18 07:40AM
Apr-05-18 07:10AM
Apr-03-18 06:00AM
Mar-22-18 08:00AM
Dec-01-17 07:58AM
Nov-15-17 06:00AM
Nov-08-17 12:20PM
Nov-07-17 08:00AM
Oct-24-17 03:48PM
Sep-26-17 12:03PM
Sep-14-17 07:40AM
Sep-12-17 04:05PM
Aug-16-17 10:08AM
Aug-15-17 06:00AM
Aug-08-17 06:00AM
May-24-17 09:18AM
May-17-17 08:30AM
May-12-17 06:00AM
May-08-17 06:00AM
Apr-04-17 08:41AM
Mar-31-17 06:11AM
06:00AM
Mar-27-17 06:00AM
Dec-28-16 04:06PM
Dec-13-16 04:08PM
Dec-02-16 04:11PM
Nov-22-16 01:04PM
Nov-18-16 11:50AM
Nov-15-16 06:00AM
Nov-14-16 04:12PM
Nov-07-16 08:00AM
Aug-12-16 06:00AM
Aug-11-16 04:27PM
Aug-01-16 06:00AM
Jun-06-16 12:12PM
May-17-16 06:00AM
May-16-16 05:17PM
May-05-16 06:00AM
Apr-05-16 11:33AM
10:27AM
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.